Having trouble accessing articles? Reset your cache.

Xifaxan rifaximin regulatory update

FDA extended the PDUFA date for an sNDA from Salix for Xifaxan rifaximin

Read the full 133 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE